Clinical trial
Study Assessing Cognitive Performance Plus Physical Activity in Patients With Relapsing-Remitting MS Under Treatment With Betaferon®
NCT01491100 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Assessing Cognitive Performance Plus Physical Activity in Patients With Relapsing-Remitting MS Under Treatment With Betaferon®
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- April 5, 2017
- Enrollment
- 1,085 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.